164 related articles for article (PubMed ID: 32015379)
1. DNA sequence context as a marker of CpG methylation instability in normal and cancer tissues.
Scala G; Federico A; Palumbo D; Cocozza S; Greco D
Sci Rep; 2020 Feb; 10(1):1721. PubMed ID: 32015379
[TBL] [Abstract][Full Text] [Related]
2. General transcription factor binding at CpG islands in normal cells correlates with resistance to de novo DNA methylation in cancer cells.
Gebhard C; Benner C; Ehrich M; Schwarzfischer L; Schilling E; Klug M; Dietmaier W; Thiede C; Holler E; Andreesen R; Rehli M
Cancer Res; 2010 Feb; 70(4):1398-407. PubMed ID: 20145141
[TBL] [Abstract][Full Text] [Related]
3. Monitoring methylation changes in cancer.
Beier V; Mund C; Hoheisel JD
Adv Biochem Eng Biotechnol; 2007; 104():1-11. PubMed ID: 17290816
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide analysis and modeling of DNA methylation susceptibility in 30 breast cancer cell lines by using CpG flanking sequences.
An J; Kim K; Rhee SM; Chae H; Nephew KP; Kim S
J Bioinform Comput Biol; 2013 Jun; 11(3):1341003. PubMed ID: 23796180
[TBL] [Abstract][Full Text] [Related]
5. DNA motifs associated with aberrant CpG island methylation.
Feltus FA; Lee EK; Costello JF; Plass C; Vertino PM
Genomics; 2006 May; 87(5):572-9. PubMed ID: 16487676
[TBL] [Abstract][Full Text] [Related]
6. Microarray-based method for detecting methylation changes of p16(Ink4a) gene 5'-CpG islands in gastric carcinomas.
Hou P; Shen JY; Ji MJ; He NY; Lu ZH
World J Gastroenterol; 2004 Dec; 10(24):3553-8. PubMed ID: 15534905
[TBL] [Abstract][Full Text] [Related]
7. A microarray to analyze methylation patterns of p16(Ink4a) gene 5'-CpG islands.
Hou P; Ji M; Liu Z; Shen J; Cheng Lu; He N; Lu Z
Clin Biochem; 2003 May; 36(3):197-202. PubMed ID: 12726928
[TBL] [Abstract][Full Text] [Related]
8. Characterization of tissue-specific differential DNA methylation suggests distinct modes of positive and negative gene expression regulation.
Wan J; Oliver VF; Wang G; Zhu H; Zack DJ; Merbs SL; Qian J
BMC Genomics; 2015 Feb; 16(1):49. PubMed ID: 25652663
[TBL] [Abstract][Full Text] [Related]
9. Identification of epigenetic modulators in human breast cancer by integrated analysis of DNA methylation and RNA-Seq data.
Zhou X; Chen Z; Cai X
Epigenetics; 2018; 13(5):473-489. PubMed ID: 29940789
[TBL] [Abstract][Full Text] [Related]
10. Loss of epigenetic silencing in tumors preferentially affects primate-specific retroelements.
Szpakowski S; Sun X; Lage JM; Dyer A; Rubinstein J; Kowalski D; Sasaki C; Costa J; Lizardi PM
Gene; 2009 Dec; 448(2):151-67. PubMed ID: 19699787
[TBL] [Abstract][Full Text] [Related]
11. Non-CpG methylation-a key epigenetic modification in cancer.
Ramasamy D; Deva Magendhra Rao AK; Rajkumar T; Mani S
Brief Funct Genomics; 2021 Sep; 20(5):304-311. PubMed ID: 34318313
[TBL] [Abstract][Full Text] [Related]
12. Oligonucleotide DNA chips are useful adjuncts in epigenetic studies of glioblastomas.
Kim B; Kim H; Song BJ; Cha SH; Lee MO; Park SH
Neuropathology; 2006 Oct; 26(5):409-16. PubMed ID: 17080717
[TBL] [Abstract][Full Text] [Related]
13. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!
van Vlodrop IJ; Niessen HE; Derks S; Baldewijns MM; van Criekinge W; Herman JG; van Engeland M
Clin Cancer Res; 2011 Jul; 17(13):4225-31. PubMed ID: 21558408
[TBL] [Abstract][Full Text] [Related]
14. Characterization of cross-tissue genetic-epigenetic effects and their patterns in schizophrenia.
Lin D; Chen J; Perrone-Bizzozero N; Bustillo JR; Du Y; Calhoun VD; Liu J
Genome Med; 2018 Feb; 10(1):13. PubMed ID: 29482655
[TBL] [Abstract][Full Text] [Related]
15. Comparison of genome-wide analysis techniques to DNA methylation analysis in human cancer.
Soozangar N; Sadeghi MR; Jeddi F; Somi MH; Shirmohamadi M; Samadi N
J Cell Physiol; 2018 May; 233(5):3968-3981. PubMed ID: 28888056
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation testing and marker validation using PCR: diagnostic applications.
Egger G; Wielscher M; Pulverer W; Kriegner A; Weinhäusel A
Expert Rev Mol Diagn; 2012 Jan; 12(1):75-92. PubMed ID: 22133121
[TBL] [Abstract][Full Text] [Related]
17. Methylation-Sensitive Amplification Length Polymorphism (MS-AFLP) Microarrays for Epigenetic Analysis of Human Genomes.
Alonso S; Suzuki K; Yamamoto F; Perucho M
Methods Mol Biol; 2018; 1766():137-156. PubMed ID: 29605851
[TBL] [Abstract][Full Text] [Related]
18. DNA methylation analysis using CpG microarrays is impaired in benzopyrene exposed cells.
Sadikovic B; Andrews J; Rodenhiser DI
Toxicol Appl Pharmacol; 2007 Dec; 225(3):300-9. PubMed ID: 17904174
[TBL] [Abstract][Full Text] [Related]
19. Using Illumina Infinium HumanMethylation 450K BeadChip to explore genome‑wide DNA methylation profiles in a human hepatocellular carcinoma cell line.
Sun N; Zhang J; Zhang C; Shi Y; Zhao B; Jiao A; Chen B
Mol Med Rep; 2018 Nov; 18(5):4446-4456. PubMed ID: 30221710
[TBL] [Abstract][Full Text] [Related]
20. [Perspective of DNA methylation in forensic genetics and new progress of its detection methods].
Zhao SM; Li CT
Fa Yi Xue Za Zhi; 2009 Aug; 25(4):290-5. PubMed ID: 19788082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
